CLINICAL_TRIALS
trial_result
· 2019-10-07
Clinical Trial Update: Role of Pepsin Assay in Wheezy Infants [Phase 4]
Summary
A Phase 4 clinical trial assessing the role of a pepsin assay in wheezy infants with gastroesophageal reflux disease has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mansoura University Children Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-10-07